Adding On to Monotherapy: Combining DDR Inhibitors

Time: 1:30 pm
day: Day Two


  • Combinations to combat emerging resistance; identifying combination agents
  • Can the combination of DDRis result in overlapping toxicity? A case study of combining PARPi and ATRi
  • Circumventing PLK inhibition: combining ATRN-W1051 with Wee1 or ATR inhibitors